AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Lonza signs manufacturing deal with biopharma firm.(PHARMACEUTICALS & FINE CHEMICALS)(EluSys Therapeutics Inc.)(Brief article)

Chemical Week

| June 22, 2009 | Ramesh, Deepti | COPYRIGHT 2003 Chemical Week Associates. (Hide copyright information)Copyright

Lonza says it has signed a deal to produce therapeutic monoclonal antibody Anthim for biopharmaceutical company Elusys Therapeutics (Pine Brook, NJ). Anthim, which is in late-stage development, can be used to treat anthrax infection. Lonza says it will provide process development services and manufacturing capacity, using its GS Gene Expression System, under the deal.

Elusys develops antibody therapeutics for treatment of …

Related articles from newspapers, magazines, journals, and more
Elusys Therapeutics and Lonza extend manufacturing agreement for Anthim, a...
News wire article from: Chemical Business Newsbase July 15, 2010 700+ words
Elusys Therapeutics and Lonza enter into manufacturing agreement.
News wire article from: Chemical Business Newsbase June 16, 2009 700+ words
Lonza signs manufacturing deal with biopharma firm.
News wire article from: Chemical Business Newsbase June 29, 2009 700+ words
Lonza gets Elusys and land in India.
News wire article from: Chemical Business Newsbase June 22, 2009 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily